| Q4  2025 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 55.80% |
2,765,985 |
0.67 |
| ≡ |
David Abrams - Abrams Capital Management |
Reduce 1.46% |
90,360 |
0.03 |
| Q3  2025 |
| ≡ |
Bill Nygren - Oakmark Funds |
Sell 100.00% |
16,500 |
0.00 |
| Q2  2025 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 16.53% |
807,407 |
0.66 |
| Q1  2025 |
| ≡ |
David Abrams - Abrams Capital Management |
Reduce 65.20% |
11,628,545 |
3.84 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Reduce 80.47% |
686,300 |
1.03 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 4.09% |
208,119 |
0.20 |
| Q4  2024 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 28.02% |
1,913,265 |
0.58 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 3.87% |
204,948 |
0.19 |
| Q3  2024 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 11.38% |
876,428 |
0.21 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 1.19% |
63,827 |
0.05 |
| Q2  2024 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 5.59% |
317,572 |
0.27 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 10.87% |
940,000 |
0.25 |
| Q1  2024 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 11.63% |
1,137,448 |
0.27 |
| Q4  2023 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 0.09% |
4,986 |
0.00 |
| Q3  2023 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Sell 100.00% |
268,700 |
0.26 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 0.51% |
28,596 |
0.02 |
| Q2  2023 |
| ≡ |
Bill Miller - Miller Value Partners |
Sell 100.00% |
4,951,231 |
3.86 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 4.13% |
421,554 |
0.10 |
| Q1  2023 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 0.91% |
45,645 |
0.04 |
| Q4  2022 |
| ≡ |
David Abrams - Abrams Capital Management |
Reduce 19.01% |
4,185,000 |
1.77 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 15.40% |
909,450 |
0.70 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 2.84% |
21,600 |
0.13 |
| Q3  2022 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 0.65% |
66,870 |
0.05 |
| ≡ |
David Abrams - Abrams Capital Management |
Reduce 0.47% |
105,000 |
0.03 |
| Q2  2022 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Reduce 68.17% |
575,500 |
0.47 |
| Q1  2022 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 25.66% |
3,179,705 |
1.42 |
| ≡ |
Bruce Berkowitz - Fairholme Capital |
Reduce 44.01% |
663,500 |
0.43 |
| ≡ |
Samantha McLemore - Patient Capital Management |
Reduce 12.57% |
87,600 |
0.39 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 11.62% |
662,249 |
0.28 |
| Q4  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 26.76% |
2,083,492 |
0.61 |
| Q3  2021 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 10.55% |
918,421 |
0.30 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 4.92% |
522,510 |
0.12 |
| Q2  2021 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 53.42% |
12,190,408 |
2.68 |
| Q1  2021 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 5.18% |
1,245,931 |
0.14 |
| ≡ |
David Katz - Matrix Asset Advisors |
Sell 100.00% |
11,544 |
0.01 |
| Q3  2020 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 0.82% |
38,698 |
0.01 |
| Q2  2020 |
| ≡ |
Bill Miller - Miller Value Partners |
Reduce 17.81% |
1,021,297 |
0.32 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 7.17% |
1,168,562 |
0.14 |
| Q2  2019 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 12.62% |
845,236 |
0.53 |
| Q1  2019 |
| ≡ |
David Tepper - Appaloosa Management |
Reduce 13.25% |
1,022,901 |
0.47 |